<html>
<head>PUBMED IDs for CDHP</head>
<body bgcolor='#C5F0F2'><h1>CDHP</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17203218/'>S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.</a> January 5  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17699726/'>Alteration of dihydropyrimidine dehydrogenase expression by IFN-alpha affects the antiproliferative effects of 5-fluorouracil in human hepatocellular carcinoma cells.</a> August 19  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17982671/'>Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma.</a> November 6  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19093184/'>Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene.</a> March 28  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19724848/'>S-1 mediates the inhibition of lymph node metastasis in oral cancer cells.</a> November 10  2009<br></body></html>
